A phase ii study on the use of convalescent plasma for the treatment of severe covid-19-a propensity score-matched control analysis

Autor: Pappa, V. Bouchla, A. Terpos, E. Thomopoulos, T.P. Rosati, M. Stellas, D. Antoniadou, A. Mentis, A. Papageorgiou, S.G. Politou, M. Kotanidou, A. Kalomenidis, I. Poulakou, G. Jahaj, E. Korompoki, E. Grigoropoulou, S. Hu, X. Bear, J. Karaliota, S. Burns, R. Pagoni, M. Trontzas, I. Grouzi, E. Labropoulou, S. Stamoulis, K. Bamias, A. Tsiodras, S. Felber, B.K. Pavlakis, G.N. Dimopoulos, M.-A.

COVID-19 is a global pandemic associated with increased morbidity and mortality. Convalescent plasma (CP) infusion is a strategy of potential therapeutic benefit. We conducted a multicenter phase II study to evaluate the efficacy and safety of CP in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::8755e9c0c863a0a8fb7b1fdec480fce4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2999910

Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers.

Autor: Sarrigeorgiou I; Immunology Laboratory, Immunology Department, Hellenic Pasteur Institute (HPI), Athens, Greece., Moschandreou D; Department of Transfusion Service and Clinical Hemostasis, 'Saint Savvas' Oncology Hospital, Athens, Greece., Dimitriadis A; Biotechnology Unit, HPI, Athens, Greece., Tsinti G; Immunology Laboratory, Immunology Department, Hellenic Pasteur Institute (HPI), Athens, Greece., Sotiropoulou E; Biotechnology Unit, HPI, Athens, Greece., Ntoukaki E; Immunology Laboratory, Immunology Department, Hellenic Pasteur Institute (HPI), Athens, Greece., Eliadis P; Biotechnology Unit, HPI, Athens, Greece.; Laboratory of Molecular Biology and Immunobiotechnology, HPI, Athens, Greece., Backovic M; Structural Virology Unit, Department of Virology, Institut Pasteur, Paris, 75015, France., Labropoulou S; Diagnostic Services Department, HPI, Athens, Greece., Escriou N; Innovation Lab, Vaccines, Department of Virology, Institut Pasteur, Paris, 75015, France., Pouliakis A; Second Department of Pathology, National and Kapodistrian University of Athens, 'ATTIKON' University Hospital, Athens, Greece., Giannopoulou G; Department of Transfusion Service and Clinical Hemostasis, 'Saint Savvas' Oncology Hospital, Athens, Greece., Gaitanarou E; Department of Transfusion Service and Clinical Hemostasis, 'Saint Savvas' Oncology Hospital, Athens, Greece., Lazaridis K; Immunology Laboratory, Immunology Department, Hellenic Pasteur Institute (HPI), Athens, Greece., Mentis A; Diagnostic Services Department, HPI, Athens, Greece., Mamalaki A; Biotechnology Unit, HPI, Athens, Greece.; Laboratory of Molecular Biology and Immunobiotechnology, HPI, Athens, Greece., Grouzi E; Department of Transfusion Service and Clinical Hemostasis, 'Saint Savvas' Oncology Hospital, Athens, Greece., Lymberi P; Immunology Laboratory, Immunology Department, Hellenic Pasteur Institute (HPI), Athens, Greece.

Publikováno v: PloS one [PLoS One] 2022 Nov 21; Vol. 17 (11), pp. e0277827. Date of Electronic Publication: 2022 Nov 21 (Print Publication: 2022).

Characterizing Kinetics and Avidity of SARS-CoV-2 Antibody Responses in COVID-19 Greek Patients.

Autor: Labropoulou S; Diagnostics Department and Public Health Laboratories, Hellenic Pasteur Institute, 11521 Athens, Greece., Vassilaki N; Laboratory of Molecular Virology, Hellenic Pasteur Institute, 127 Vasilissis Sofias Avenue, 11521 Athens, Greece., Milona RS; Laboratory of Molecular Virology, Hellenic Pasteur Institute, 127 Vasilissis Sofias Avenue, 11521 Athens, Greece., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Politou M; Hematology Laboratory Blood Bank, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece., Pappa V; Hematology Unit, Second Department of Internal Medicine, School of Medicine, Attikon University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece., Pagoni M; BMT Unit, Department of Hematology and Lymphomas, Evangelismos General Hospital, 10676 Athens, Greece., Grouzi E; Department of Transfusion Service and Clinical Hemostasis, 'Saint Savvas' Oncology Hospital, 11522 Athens, Greece., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Mentis A; Diagnostics Department and Public Health Laboratories, Hellenic Pasteur Institute, 11521 Athens, Greece., Emmanouil M; Diagnostics Department and Public Health Laboratories, Hellenic Pasteur Institute, 11521 Athens, Greece., Angelakis E; Diagnostics Department and Public Health Laboratories, Hellenic Pasteur Institute, 11521 Athens, Greece.; IHU-Méditerranée Infection, Aix-Marseille University, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Publikováno v: Viruses [Viruses] 2022 Apr 05; Vol. 14 (4). Date of Electronic Publication: 2022 Apr 05.

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.

Autor: Pappa V; Hematology Unit, Second Propaedeutic Department of Internal Medicine and Research Institute, School of Medicine National and Kapodistrian University of Athens, University General Hospital 'Attikon', 18120 Athens, Greece., Bouchla A; Hematology Unit, Second Propaedeutic Department of Internal Medicine and Research Institute, School of Medicine National and Kapodistrian University of Athens, University General Hospital 'Attikon', 18120 Athens, Greece., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Thomopoulos TP; Hematology Unit, Second Propaedeutic Department of Internal Medicine and Research Institute, School of Medicine National and Kapodistrian University of Athens, University General Hospital 'Attikon', 18120 Athens, Greece., Rosati M; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA., Stellas D; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.; National Hellenic Research Foundation, Institute of Chemical Biology, 11635 Athens, Greece., Antoniadou A; Fourth Department of Internal Medicine, University General Hospital 'Attikon', School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Mentis A; National Influenza Reference Laboratory of Southern Greece, Hellenic Pasteur Institute, 11521 Athens, Greece., Papageorgiou SG; Hematology Unit, Second Propaedeutic Department of Internal Medicine and Research Institute, School of Medicine National and Kapodistrian University of Athens, University General Hospital 'Attikon', 18120 Athens, Greece., Politou M; Hematology Laboratory-Blood Bank, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Kotanidou A; First Department of Critical Care Medicine and Pulmonary Services, Evangelismos General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece., Kalomenidis I; First Department of Critical Care Medicine and Pulmonary Services, Evangelismos General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece., Poulakou G; 3rd Department of Internal Medicine, Sotiria General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Jahaj E; First Department of Critical Care Medicine and Pulmonary Services, Evangelismos General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece., Korompoki E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Grigoropoulou S; Fourth Department of Internal Medicine, University General Hospital 'Attikon', School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Hu X; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA., Bear J; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA., Karaliota S; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA., Burns R; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA., Pagoni M; Haematology-Lymphomas Department and BMT Unit, Evangelismos Hospital, 10676 Athens, Greece., Trontzas I; 3rd Department of Internal Medicine, Sotiria General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Grouzi E; Transfusion Service and Clinical Hemostasis of Saint Savvas, Oncology Hospital of Athens, 11522 Athens, Greece., Labropoulou S; National Influenza Reference Laboratory of Southern Greece, Hellenic Pasteur Institute, 11521 Athens, Greece., Stamoulis K; Hellenic National Blood Transfusion Center, 13678 Athens, Greece., Bamias A; Hematology Unit, Second Propaedeutic Department of Internal Medicine and Research Institute, School of Medicine National and Kapodistrian University of Athens, University General Hospital 'Attikon', 18120 Athens, Greece., Tsiodras S; Fourth Department of Internal Medicine, University General Hospital 'Attikon', School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA., Pavlakis GN; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.

Publikováno v: Microorganisms [Microorganisms] 2021 Apr 11; Vol. 9 (4). Date of Electronic Publication: 2021 Apr 11.

Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.

Autor: Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Politou M; Hematology Laboratory Blood Bank, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Sergentanis TN; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Mentis A; Public Health Laboratories, Hellenic Pasteur Institute, 11521 Athens, Greece., Rosati M; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA., Stellas D; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.; Institute of Chemical Biology, National Hellenic Research Foundation, 48 Vassileos Constantinou Ave., 11635 Athens, Greece., Bear J; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA., Hu X; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA., Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA., Pappa V; Hematology Unit, Second Department of Internal Medicine, Attikon University General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Pagoni M; BMT Unit, Department of Hematology and Lymphomas, Evangelismos General Hospital, 10676 Athens, Greece., Grouzi E; Department of Transfusion Service and Clinical Hemostasis, 'Saint Savvas' Oncology Hospital, 11522 Athens, Greece., Labropoulou S; Public Health Laboratories, Hellenic Pasteur Institute, 11521 Athens, Greece., Charitaki I; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Moschandreou D; Department of Transfusion Service and Clinical Hemostasis, 'Saint Savvas' Oncology Hospital, 11522 Athens, Greece., Bouhla A; Hematology Unit, Second Department of Internal Medicine, Attikon University General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Saridakis S; Blood Bank, Evangelismos General Hospital, 10442 Athens, Greece., Korompoki E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Giatra C; BMT Unit, Department of Hematology and Lymphomas, Evangelismos General Hospital, 10676 Athens, Greece., Bagratuni T; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Pefanis A; Department of Internal Medicine, Sotiria General Hospital of Chest Diseases, 11527 Athens, Greece., Papageorgiou S; Hematology Unit, Second Department of Internal Medicine, Attikon University General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Spyridonidis A; BMT Unit, University Hospital of Patras, School of Medicine, University of Patras, 26500 Patras, Greece., Antoniadou A; Fourth Department of Internal Medicine, Attikon University General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Kotanidou A; First Department of Critical Care Medicine and Pulmonary Services, Evangelismos General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Syrigos K; Oncology Unit, Third Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece., Stamoulis K; Hellenic National Blood Transfusion Center, 13678 Athens, Greece., Panayiotakopoulos G; Pharmacology Laboratory, School of Medicine, University of Patras, 26500 Patras, Greece.; National Public Health Organization, 15123 Athens, Greece., Tsiodras S; Fourth Department of Internal Medicine, Attikon University General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.; National Public Health Organization, 15123 Athens, Greece., Alexopoulos L; Biomedical Systems Laboratory, National Technical University of Athens, 11527 Athens, Greece., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece., Pavlakis GN; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.

Publikováno v: Microorganisms [Microorganisms] 2020 Nov 28; Vol. 8 (12). Date of Electronic Publication: 2020 Nov 28.